Optimizing treatment strategies for intermediate-to-high risk pulmonary embolism

Pulmonary embolism (PE) is a life-threatening condition that requires prompt and effective management. With the growing body of evidence and advancements in medical and interventional therapies, the optimal treatment strategy for intermediate-to-high risk PE has become a subject of debate [ [1] Konstantinides S.V. Meyer G. Becattini C. Bueno H. Geersing G.-J. Harjola V.-P. Huisman M.V. Humbert M. Jennings C.S. Jiménez D. Kucher N. Lang I.M. Lankeit M. Lorusso R. Mazzolai L. Meneveau N. Ní Áinle F. Prandoni P. Pruszczyk P. Righini M. Torbicki A. Van Belle E. Zamorano J.L. ESC Scientific Document Group 2019 ESC guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS). Eur. Heart J. 2020; 41: 543-603https://doi.org/10.1093/eurheartj/ehz405 Crossref PubMed Scopus (1875) Google Scholar ]. Mortality across treatment strategies in intermediate-to-high risk pulmonary embolism in the modern era: A meta-analysis of observational studies and RCTsInternational Journal of CardiologyVol. 387PreviewPulmonary embolism (PE) represents one of the leading causes of death worldwide and mainly treated with medical management, although the utility of more invasive approaches has emerged more recently. This meta-analysis aims to evaluate the 30-day mortality of intermediate-to-high risk PE across different treatment strategies. Full-Text PDF